Exome Asset Management’s Sagimet Biosciences SGMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50,700	Closed	-$173K	–	77
2024 Q2	$173K	Sell	50,700 -10,200	-17%	-$34.9K	0.15%	51
2024 Q1	$330K	Buy	+60,900	New	+$330K	0.28%	51